One swab, two tests: Validation of dual SARS-CoV-2 testing on the Abbott ID NOW™

BACKGROUND: Point-of-care tests (POCT) are promising tools to detect SARS-CoV-2 in specific settings. Initial reports suggest the ID NOW™ COVID-19 assay (Abbott Diagnostics Inc, USA) is less sensitive than standard real-time reverse transcription polymerase chain reaction (rRT-PCR) assays. This has...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Virol
Autors principals: Burnes, Laura E, Clark, Shawn T, Sheldrake, Elena, Faheem, Amna, Poon, Betty P, Christie-Holmes, Natasha, Finlay, Laura, Kandel, Christopher, Phan, Michael, Frankland, Caylin, Lau, Trevor, Gubbay, Jonathan B, Corbeil, Antoine, Katz, Kevin, Kozak, Robert A.
Format: Artigo
Idioma:Inglês
Publicat: The Authors. Published by Elsevier B.V. 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8196482/
https://ncbi.nlm.nih.gov/pubmed/34174710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcv.2021.104896
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars